IO Biotech Inc
NASDAQ:IOBT

Watchlist Manager
IO Biotech Inc Logo
IO Biotech Inc
NASDAQ:IOBT
Watchlist
Price: 0.622 USD -2.03%
Market Cap: 44.8m USD

Net Margin
IO Biotech Inc

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-88.3m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

IO Biotech Inc
Glance View

Market Cap
43.3m USD
Industry
Biotechnology

IO Biotech, Inc. is a clinical stage biotechnology company. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.

IOBT Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-88.3m
/
Revenue
0
What is the Net Margin of IO Biotech Inc?

Based on IO Biotech Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top